Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Solid Tumor, Adult × tislelizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 18 Stomach Neoplasms 11 Carcinoma, Hepatocellular 10 Esophageal Squamous Cell Carcinoma 7 Squamous Cell Carcinoma of Head and Neck 6 Colorectal Neoplasms 6 Lung Neoplasms 5 Advanced Solid Tumor 4 Triple Negative Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Rectal Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Squamous Cell Carcinoma of External Auditory Canal 1 Solid Tumor, Adult 1 Solid Tumor 1 Small Cell Lung Cancer Extensive Stage 1 Simpson-Golabi-Behmel syndrome 1 Renal Pelvic Carcinoma 1 Recurrence 1 Pseudomyxoma Peritonei 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1

Interventions

pembrolizumab 2 toripalimab 1 tislelizumab 1 spartalizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 lenvatinib 1 atezolizumab 1 abemaciclib 1 Trastuzumab 1 Tiragolumab 1 Fulvestrant 1 Cryosurgery 1 Catalytic Domain 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06032845 2025-02-27

CASTLE-11

Fudan University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡